Printer Friendly
The Free Library
14,715,918 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Kobayashi Pharmaceutical to Market New Nutritional Supplement Product via Mail-Order.


Tokyo, Japan, June 23, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - On June 21, Kobayashi Pharmaceutical launched a nutritional supplement product, Jukkoku Kenko Tsubu.

The new product contains ingredients derived from black rice, black beans black bean

see castanospermum australe, erythrophleumchlorostachys.
 and other ingredients, and helps maintain health and vitality vi·tal·i·ty
n.
1. The capacity to live, grow, or develop.

2. Physical or intellectual vigor; energy.
.

The 180-tablet bottle sells for 1,995 yen (US$17.30). The new product is only available via mail-order, phone, fax, Internet Internet

Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the
 and exclusive postcard.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jun 23, 2006
Words:74
Previous Article:Kyowa Hakko Kogyo to Expand Its Fuji Plant and Accelerate R&D for Antibody Drugs.
Next Article:Banyu Pharmaceutical Announces Subanalysis of J-LIT, Large-scale Clinical Trials of Anti-hyperlipidemic Agent LIPOVAS.



Related Articles
Perish the paradox: using analytics to unearth true intelligence in customer interactions. (Call Center/CRM Management Scope).
AUSTCANCER APPOINTS SINGAPORE DISTRIBUTOR FOR REVISYS.
Kobayashi Pharmaceutical Reports Financial Results for the First Quarter Ended June 30, 2005.
Kobayashi Pharmaceutical Reports Results for the First Half Ended September 30, 2005.
HABA to Market New Supplement in February.
Kobayashi Pharmaceutical Launches New Supplement.
Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the First Quarter Ended June 30, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the First Half Ended Sept. 30, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2007.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles